#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Study of ETX-19477 for Patients with Advanced Solid Tumors After Standard Treatment

    Recruiting

    2 1 1
    Investigated Drugs:
    France Italy Spain

  • Study of PF-06821497 and Enzalutamide for Men with Advanced Prostate Cancer Resistant to Hormone Therapy

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Denmark Finland France Germany +8

  • Study Comparing Docetaxel and Androgen Receptor-Targeted Agents (Abiraterone or Enzalutamide) for Patients with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study of Ebastine and Docetaxel for Treating Metastatic Castration-Resistant Prostate Cancer in Patients with Advanced Disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study of Opevesostat, Olaparib, and Cabazitaxel in Patients with Advanced Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Finland France Germany Ireland Italy +2

  • Study on the Safety and Effects of Lutetium (177Lu) Vipivotide Tetraxetan in Adults with Metastatic Castration-Resistant Prostate Cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany The Netherlands Spain

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy and Chemotherapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Czechia Denmark Finland France Germany +8

  • Study Comparing MK-5684 with Abiraterone Acetate or Enzalutamide for Patients with Advanced Prostate Cancer After Hormonal Therapy

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Czechia Estonia France Germany Greece Hungary +9

  • Study on the Safety and Effects of XL092 with Nivolumab, Ipilimumab, and Relatlimab for Patients with Advanced Solid Tumors

    Recruiting

    1 1 1 1
    Investigated Drugs:
    Austria Belgium France Germany Italy Poland +1

  • Study of Tulmimetostat (CPI-0209) for Patients with Advanced Solid Tumors and Lymphomas

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Italy Poland Spain